Effects of Low Dose Pioglitazone on Restenosis and Coronary Atherosclerosis in Diabetic Patients Undergoing Drug Eluting Stent Implantation
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
PURPOSE: Thiazolidinediones are insulin-sensitizing agents that reduce neointimal proliferation and the adverse clinical outcomes associated with percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM). There is little data on whether or not low dose pioglitazone reduces adverse clinical outcomes. MATERIALS AND METHODS: The study population included 121 DM patients with coronary artery disease and they were randomly assigned to 60 patients taking 15 mg of pioglitazone daily in addition to their diabetic medications and 61 patients with placebo after the index procedure with drug-eluting stents (DESs). The primary end points were rate of in-stent restenosis (ISR) and change in atheroma volume and in-stent neointimal volume. The secondary end points were all-cause death, myocardial infarction (MI), stent thrombosis and re-PCI. RESULTS: There were no statistical differences in the clinical outcomes and the rate of ISR between the two groups [all-cause death; n=0 (0%) in the pioglitazone group vs. n=1 (1.6%) in the control group, p=0.504, MI; n=2 (3.3%) vs. n=1 (1.6%), p=0.465, re-PCI; n=6 (10.0%) vs. n=6 (9.8%), p=0.652, ISR; n=4 (9.3%) vs. n=4 (7.5%), p=1.000, respectively]. There were no differences in changes in neointimal volume, percent neointimal volume, total plaque volume and percent plaque volume between the two groups on intravascular ultrasonography (IVUS) study. CONCLUSION: Our study demonstrated that low dose pioglitazone does not reduce rate of ISR, neointimal volume nor atheroma volume in DM patients who have undergone PCI with DESs, despite the limitations of the study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., Davignon, J., Erbel, R., Fruchart, J. C., Tardif, J.-C., et al. (2006) · JAMA · doi:10.1001/jama.295.13.jpc60002 · Cited by 2,047
Lincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
Singh, S., Loke, Y. K., & Furberg, C. D. (2007) · JAMA · doi:10.1001/jama.298.10.1189 · Cited by 5
Research works printed but not linked: 24
- Yki-Järvinen, 2004, N Engl J Med, 351, 1106, 10.1056/NEJMra041001 · DOI · Paper page
- Takagi, 2003, Am Heart J, 146, E5, 10.1016/S0002-8703(03)00146-7 · DOI
- Takagi, 2000, J Am Coll Cardiol, 36, 1529, 10.1016/S0735-1097(00)00895-0 · DOI · Paper page
- Takagi, 2002, Am J Cardiol, 89, 318, 10.1016/S0002-9149(01)02232-9 · doi:10.1016/s0002-9149(01)02232-9
- Takagi, 2005, J Cardiol, 45, 139
- Choi, 2004, Diabetes Care, 27, 2654, 10.2337/diacare.27.11.2654 · DOI · Paper page
- Osman, 2004, Am Heart J, 147, e23, 10.1016/j.ahj.2003.12.006 · DOI
- Nissen, 2007, N Engl J Med, 356, 2457, 10.1056/NEJMoa072761 · DOI · Paper page
- Dormandy, 2005, Lancet, 366, 1279, 10.1016/S0140-6736(05)67528-9 · DOI · Paper page
- Takagi, 2009, JACC Cardiovasc Interv, 2, 524, 10.1016/j.jcin.2009.04.007 · DOI
- Goetze, 1999, J Cardiovasc Pharmacol, 33, 798, 10.1097/00005344-199905000-00018 · DOI · Paper page
- Igarashi, 2001, Metabolism, 50, 955, 10.1053/meta.2001.24869 · DOI
- Law, 2000, Circulation, 101, 1311, 10.1161/01.CIR.101.11.1311 · DOI · Paper page
- Marx, 2005, Circulation, 112, 2792, 10.1161/CIRCULATIONAHA.105.535484 · DOI · Paper page
- Nissen, 2008, JAMA, 299, 1561, 10.1001/jama.299.13.1561 · DOI · Paper page
- Aizawa, 2001, Circulation, 104, 455, 10.1161/hc3001.092040 · DOI
- Jiang, 1998, Nature, 391, 82, 10.1038/35154 · DOI · Paper page
- Hahn, 2006, Int J Cardiol, 109, 267, 10.1016/j.ijcard.2005.04.015 · doi:10.1016/j.ijcard.2005.04.015
- Delhaye, 2010, Am J Cardiol, 105, 826, 10.1016/j.amjcard.2009.10.064 · DOI
- Patel, 2011, JACC Cardiovasc Interv, 4, 353, 10.1016/j.jcin.2010.10.016 · DOI
- Rosmarakis, 2007, Am Heart J, 154, 144, 10.1016/j.ahj.2007.04.005 · DOI
- Joner, 2007, Arterioscler Thromb Vasc Biol, 27, 182, 10.1161/01.ATV.0000251021.28725.e8 · DOI
- Langenfeld, 2005, Circulation, 111, 2525, 10.1161/01.CIR.0000165072.01672.21 · DOI · Paper page
- Sidhu, 2004, Arterioscler Thromb Vasc Biol, 24, 930, 10.1161/01.ATV.0000124890.40436.77 · DOI · Paper page
Cited by
Palmer, S. C., Tendal, B., Mustafa, R. A., Vandvik, P. O., Li, S., Hao, Q., Tunnicliffe, D., Ruospo, M., Natale, P., Saglimbene, V., et al. (2021) · BMJ · doi:10.1136/bmj.m4573 · Cited by 679
Liao, H.-W., Saver, J. L., Wu, Y.-L., Chen, T.-H., Lee, M., & Ovbiagele, B. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013927 · Cited by 198
Zhou, Y., Huang, Y., Ji, X., Wang, X., Shen, L., & Wang, Y. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz252 · Cited by 81
Sinha, B., & Ghosal, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-72967-8 · Cited by 46
Metadata
- Authors
- Lee, H. W., Lee, H. C., Kim, B. W., Yang, M. J., Park, J. S., Oh, J. H., Choi, J. H., Cha, K. S., Hong, T. J., Kim, S.-P., Song, S., & Park, J.-H.
- Venue
- Yonsei Medical Journal
- Publisher
- XMLink
- Published
- 2013
- Volume
- 54
- Issue
- 6
- Pages
- 1313
- ISSN
- 0513-5796 (ISSN-L)
- 1976-2437
- OpenAlex
- W2134177734
- Cited by
- 16
- References
- 3
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
- Funders
- Ministry of Health and Welfare (A070001)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Low Dose Pioglitazone on Restenosis and Coronary Atherosclerosis in Diabetic Patients Undergoing Drug Eluting Stent Implantation. https://app.cochat.ai/papers/10.3349/ymj.2013.54.6.1313
- The paper
- Lee, H. W., Lee, H. C., Kim, B. W., Yang, M. J., Park, J. S., Oh, J. H., Choi, J. H., Cha, K. S., Hong, T. J., Kim, S.-P., Song, S., & Park, J.-H. (2013). Effects of Low Dose Pioglitazone on Restenosis and Coronary Atherosclerosis in Diabetic Patients Undergoing Drug Eluting Stent Implantation. Yonsei Medical Journal. https://doi.org/10.3349/ymj.2013.54.6.1313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.